Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The big players of the industry are thus looking... Read more
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 billion, which is about 10 percent lower than the... Read more
Compared to 2011, global pharmaceutical and biotechnology sectors suffered a setback in the number of mergers and acquisitions (M&A) deals, including reverse mergers,... Read more
The M&A climate had started to heat up in 2012, and it is likely to get hotter in 2013. The majority of China's 2012 deal activities was related to drug manufacturing... Read more
Singapore: MMRGlobal announced that through its China joint venture, Unis-Tonghe MMR International Health Management Service, with JV partner Unis-Tonghe Technology... Read more
Singapore: China Botanic Pharmaceuticals, a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines... Read more
Singapore: According to a Frost and Sullivan report, Asia Pacific hospital market earned revenues of more than $377.90 billion in 2012 and estimates this to reach... Read more
Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting article titled 'The Asia-Pacific medtech market... Read more
Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer contract manufacturing to Chinese companies... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
